Have a website account? Login or Register for exclusive

Lung Surgery

Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond


This video is available to purchase. $0.0 Purchase


Cite this video as: Joel W. Neal, Lecia V. Sequist . Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond. Asvide 2014; 1: 198. doi:10.3978/asvide.2014.198

Your Comments

comments powered by Disqus

Published online:

Submitted at: May 10, 2014. Accepted for publication:
DOI: 10.3978/asvide.2014.198

Authors

Joel W. Neal 1 , Lecia V. Sequist 2

Affiliations

1 Assistant Professor of Medicine (Oncology). Stanford Cancer Center, 875 Blake Wilbur Drive, CC 2220, Stanford, CA 94305-5826, USA.
2 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

Corresponding Author

Joel W. Neal, Email: jwneal@stanford.edu